A cell therapy that uses gene-edited regulatory T cells (Tregs) with the SRC-3 gene knocked out to enable the immune system to recognize and eradicate solid tumors without toxicity.

A cell therapy using gene-edited regulatory T cells from donors with the SRC-3 gene knocked out, intended to treat solid cancers by enabling immune-mediated tumor eradication.